Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01247844
Other study ID # 10214
Secondary ID
Status Completed
Phase N/A
First received September 7, 2010
Last updated March 4, 2015
Start date September 2010
Est. completion date January 2011

Study information

Verified date March 2015
Source FHI 360
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardKenya: National Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this research study is to evaluate the safety and acceptability of the Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device with a potential role in the safe and cost-effective delivery of circumcision services. The device, developed in China, consists of two concentric plastic rings. Following a ring penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is everted over the inner ring and the larger outer ring is secured over the inner ring. The foreskin is excised and several nicks are made on the incision line to prevent formation of a constricting, circumferential scab. No suturing is required.

In this study, the investigators will evaluate wound healing of men randomized to removal of the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the device on for 14 or 21 days constitutes extended wear of the device.

Sites: Homa Bay District Hospital, Nyanza Province, Kenya


Description:

The objective of this research study is to evaluate the safety and acceptability of the Shang Ring method of medical male circumcision. The Shang Ring is a new circumcision device with a potential role in the safe and cost-effective delivery of circumcision services. The device, developed in China, consists of two concentric plastic rings. Following a ring penile block, the smaller ring is fitted at the base of the coronal sulcus. The foreskin is everted over the inner ring and the larger outer ring is secured over the inner ring. The foreskin is excised and several nicks are made on the incision line to prevent formation of a constricting, circumferential scab. No suturing is required.

In this study, we will evaluate wound healing of men randomized to removal of the Shang Ring at one of three different points in time (Days 7, 14 or 21). Leaving the device on for 14 or 21 days constitutes extended wear of the device.

Although male circumcision has a demonstrated protective effect against HIV transmission, currently available surgical techniques and devices have limitations for widespread deployment in resource-poor areas. High costs and scarcity of trained providers hinder access to male circumcision services in resource-poor areas. Its simple design sets the Shang Ring apart from other male circumcision techniques. The Shang Ring has the potential for safe, effective and inexpensive delivery of male circumcision by trained healthcare personnel in HIV endemic countries.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date January 2011
Est. primary completion date January 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 54 Years
Eligibility Inclusion Criteria:

- Must be aged 18 and 54 years;

- Must be uncircumcised (on examination);

- Must be in good general health;

- Must be HIV sero-negative, with documentation of testing no mor than one week before the procedure;

- Must be free of genital ulcerations or other visible signs of sexually transmissible infections(STI) on examination;

- Must be able to understand study procedures and requirements of study participation;

- Must agree to return to the healthcare facility for the full schedule of follow-up visits after his circumcision;

- Must freely consent to participate in the study and sign a written informed consent form;

- Must have a cell phone or access to a cell phone; and,

- Must agree to provide the study staff with an address, phone number, or other locator information while participating in the research study.

Exclusion Criteria:

- Has a known allergy or sensitivity to lidocaine or other local anesthesia;

- Takes a medication that would be a contraindication for elective surgery, such as an anticoagulant or steroid;

- Has an active genital infection, anatomic abnormality or other condition, which in the opinion of the surgeon, prevents the man from undergoing a circumcision;

- Has known bleeding/clotting disorder (e.g. hemophilia); and,

- Has thalassemia (an inherited autosomal recessive blood disease).

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Device:
Shang Ring
The Shang Ring is a sterile device consisting of two concentric medical grade plastic rings: an inner ring with a silicone band and an outer, hinged ring. The inner ring fits inside the outer ring which will lock when snapped together. The Shang Ring comes in multiple sizes. The appropriate size is determined through use of a measuring strip. The man must return to the clinic for device removal. To remove the device, the outer ring locking mechanism is broken open using a tool that is similar to a scalpel handle. Then, a pair of special scissors, specifically designed for this purpose, is used to remove the inner ring after healing

Locations

Country Name City State
Kenya Homa Bay District Hospital Homa Bay Nyanza

Sponsors (5)

Lead Sponsor Collaborator
FHI 360 Cornell University, EngenderHealth, Kenya National AIDS & STI Control Programme, Ministry of Medical Services, Kenya

Country where clinical trial is conducted

Kenya, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asses healing time Assess healing time from date of circumcision six weeks Yes
Primary spontaneous detachment of device Spontaneous detachment from date of circumcision to three weeks post procedure 21 days Yes
See also
  Status Clinical Trial Phase
Completed NCT02242565 - Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia N/A
Completed NCT00993811 - The Shang Ring: A Novel Male Circumcision Device for HIV Prevention Phase 1
Completed NCT02281435 - Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects N/A
Completed NCT04263064 - High Volume Caudal Study Early Phase 1
Completed NCT02091726 - Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive N/A
Completed NCT02309710 - Male Circumcision (MC) Using the ShangRing™ Device in Malawi Phase 1
Completed NCT02167776 - From Obstacles to Opportunities for Male Circumcision in Tanzania N/A
Completed NCT01150370 - A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings N/A
Completed NCT01434628 - Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When Performed by Nurses N/A
Active, not recruiting NCT03914365 - Pudendal Nerve Block vs Penile Nerve Block for Analgesia During Pediatric Circumcision N/A
Completed NCT01921608 - Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV N/A
Completed NCT03634358 - Bipolar Scissors for Circumcision N/A
Completed NCT02277795 - Evaluation of the AccuCirc for Early Infant Male Circumcision in Nyanza, Kenya N/A
Completed NCT01567436 - A Prospective Field Study: Introducing the Shang Ring in Routine Clinical Settings Phase 4
Completed NCT03223532 - Randomized Trial Comparing PrePex Day 7 Foreskin Removal Procedure (FRP) to a Day 0 PrePex FRP . N/A